New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 28, 2013
10:15 EDTFURX, YOKU, AKRX, LGCY, PRGO, WU, ACAD, DVAOn The Fly: Analyst Initiation SummaryWestern Union
Today's noteworthy initiations include: Akorn (AKRX) initiated with a Sector Perform at RBC Capital... DaVita (DVA) initiated with a Market Perform at Bernstein... Perrigo (PRGO) initiated with a Sector Perform at RBC Capital... Youku Tudou (YOKU) initiated with a Buy at Deutsche Bank... ACADIA (ACAD) initiated with an Outperform at Cowen... Furiex (FURX) initiated with a Buy at Canaccord... Legacy Reserves (LGCY) initiated with a Buy at Ladenburg... PBF Energy (WU) initiated with a Buy at Dahlman Rose.
News For AKRX;DVA;PRGO;YOKU;ACAD;LGCY;FURX;WU From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
February 27, 2015
07:24 EDTAKRXAkorn downgraded to Hold after share rally at Needham
Subscribe for More Information
06:49 EDTAKRXAkorn downgraded to Hold from Buy at Needham
Subscribe for More Information
06:39 EDTAKRXAkorn price target raised to $66 from $55 at Piper Jaffray
Subscribe for More Information
06:13 EDTAKRXAkorn price target raised to $65 from $43 at WallachBeth
Subscribe for More Information
February 26, 2015
18:43 EDTACADOn The Fly: After Hours Movers
Subscribe for More Information
16:14 EDTACADACADIA reports Q4 EPS (28c), consensus (26c)
Subscribe for More Information
13:05 EDTAKRXAkorn price target raised to $60 from $50 at Guggenheim
Guggenheim raised Buy rated Akron's price target to $60 from $50 following the Q4 report. The analyst believes Akorn is well positioned for upward earnings revisions that will drive shares higher in 2015.
07:17 EDTAKRXAkorn sees Q1 revenue down sequentially from Q4
Q1 revenue consensus $217.62M. The company said: "Based on several previously disclosed factors contributing to Q4 performance including higher-than-normal in-transit revenue at the end of the Q3, seasonality in the Hi-Tech Pharmacal cough and cold business and the successful resolution of backorders from the third quarter encountered due to clobetasol market dynamics, the company believes 1Q15 revenue will be below 4Q14 revenue. Akorn projects that consolidated net revenue will increase sequentially throughout 2015 due to a combination of seasonality in the business and the cumulative impact of new launches on quarterly revenue throughout the year."
07:14 EDTAKRXAkorn sees FY15 adjusted EPS $1.88-$1.98, consensus $1.82
Subscribe for More Information
07:12 EDTAKRXAkorn reports Q4 adjusted EPS 50c, consensus 45c
Subscribe for More Information
February 25, 2015
16:59 EDTLGCYLegacy Reserves reports Q4 EPS ($4.94), may not compare to consensus 12c
Subscribe for More Information
February 24, 2015
12:22 EDTACADOn The Fly: Analyst Initiation Summary
Subscribe for More Information
07:06 EDTACADACADIA initiated with a Buy at H.C. Wainwright
Subscribe for More Information
February 23, 2015
08:05 EDTDVACMS releases preliminary Medicare Advantage rates for 2016
Subscribe for More Information
February 20, 2015
07:08 EDTPRGOAmerican Academy of Allergy, Asthma and Immunology to hold annual meeting
2015 Annual Meeting of AAAAI is being held in Houston, Texas on February 20-24.
February 18, 2015
10:32 EDTWUOptions with decreasing implied volatility
Subscribe for More Information
07:53 EDTPRGOPerrigo management to meet with UBS
Meetings to be held in Minneapolis/Milwaukee on February 18 hosted by UBS.
February 17, 2015
17:29 EDTDVABerkshire Hathaway gives quarterly update on stakes, exits Exxon Mobil
Subscribe for More Information
08:18 EDTPRGOPerrigo weakness creates buying opportunity, says Argus
Subscribe for More Information
07:24 EDTPRGOPerrigo management to meet with UBS
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use